Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check10 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedA new version of the clinical trial study on Pembrolizumab for Hepatitis B-related liver cancer has been added, replacing the previous version, with updates noted in the revision history.SummaryDifference2%
- Check46 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check61 days agoChange DetectedThe website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check75 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and selecting specific fields, while the previous version v2.12.1 has been removed.SummaryDifference4%
Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.